![Antibody plasma image/ IMAGE CREDIT: PAM LI / JOHNS HOPKINS UNIVERSITY](https://watson.brown.edu/chrhs/files/chrhs/styles/trilistimage180/public/imce/research/antibody%20plasma%20final_200.jpg?itok=d6rh7GbK)
Clinical Trial for Convalescent Serum Therapy to Treat COVID-19
Lifespan/Brown University has been included in the first round of sites selected for the CSSC-001 and CSSC-004 convalescent plasma studies being run by Johns Hopkins University. Lead by Adam Levine (Site PI), Lifespan/Brown was selected as one of the first 10 sites for two major protocols: (1) post exposure prophylaxis and (2) mild outpatient disease.